patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Free
Message: NEWS PLX CELLS SELECTED FOR EUROPEAN MEDICINES PILOT PROJECT

YAHOO.COM NEWS

Significant Progress for Pluristem: PLX Cells Were Selected for European Medicines Agency's Adaptive Pathways Pilot Project

Pluristem is Targeting Critical Limb Ischemia as the First Indication for Initial Marketing Authorization, Potentially Substantially Shortening the Time to Market of PLX Cells Via the Adaptive Pathways

Share
New Message
Please login to post a reply